Barbados vs Russian Federation: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Barbados
94.0%
in 2024
Russian Federation
94.0%
in 2024
Barbados rank
34th
Russian Federation rank
34th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Barbados
- Russian Federation
How they compare
Barbados currently reports 94.0% against 94.0% in Russian Federation, a difference of 0.0%.
The two have swapped places 1 time across 9 shared years of data; in 2016 it was Barbados ahead.
Barbados ranks 34th and Russian Federation ranks 34th of 146 countries.
Across the 2 decades both report, Barbados averaged higher in 1 and Russian Federation in 1.
Head to head by decade
| Decade | Barbados | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.8% | 67.8% | 24.0% | Barbados |
| 2020s | 87.2% | 91.0% | 3.8% | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Barbados or Russian Federation?
- Barbados, at 94.0% against 94.0% in Russian Federation as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Barbados and Russian Federation?
- 0.0%, with Barbados ahead.
- How many years of comparable data are there for Barbados and Russian Federation?
- 9 years are reported by both, from 2016 to 2024.
- How do Barbados and Russian Federation rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Barbados ranks 34th and Russian Federation ranks 34th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.